Gilead Sciences (Brazil) Buy Hold or Sell Recommendation
| GILD34 Stock | BRL 273.00 2.87 1.04% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Gilead Sciences is 'Buy'. Macroaxis provides Gilead Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GILD34 positions.
Check out Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide. In addition, we conduct extensive research on individual companies such as Gilead and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Gilead |
Execute Gilead Sciences Buy or Sell Advice
The Gilead recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Gilead Sciences. Macroaxis does not own or have any residual interests in Gilead Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Gilead Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Gilead Sciences Trading Alerts and Improvement Suggestions
| Gilead Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations |
Gilead Sciences Returns Distribution Density
The distribution of Gilead Sciences' historical returns is an attempt to chart the uncertainty of Gilead Sciences' future price movements. The chart of the probability distribution of Gilead Sciences daily returns describes the distribution of returns around its average expected value. We use Gilead Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Gilead Sciences returns is essential to provide solid investment advice for Gilead Sciences.
| Mean Return | 0.29 | Value At Risk | -2.91 | Potential Upside | 2.10 | Standard Deviation | 1.73 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Gilead Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Gilead Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Gilead Sciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Gilead Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Gilead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | 0.02 | |
σ | Overall volatility | 1.81 | |
Ir | Information ratio | 0.17 |
Gilead Sciences Volatility Alert
Gilead Sciences currently demonstrates below-average downside deviation. It has Information Ratio of 0.17 and Jensen Alpha of 0.28. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Gilead Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Gilead Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Gilead Sciences Fundamentals Vs Peers
Comparing Gilead Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Gilead Sciences' direct or indirect competition across all of the common fundamentals between Gilead Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Gilead Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Gilead Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Gilead Sciences to competition |
| Fundamentals | Gilead Sciences | Peer Average |
| Return On Equity | 0.22 | -0.31 |
| Return On Asset | 0.1 | -0.14 |
| Profit Margin | 0.17 % | (1.27) % |
| Operating Margin | 0.40 % | (5.51) % |
| Current Valuation | 686.18 B | 16.62 B |
| Shares Outstanding | 2.49 B | 571.82 M |
| Price To Earning | 28.35 X | 28.72 X |
| Price To Book | 5.30 X | 9.51 X |
| Price To Sales | 21.27 X | 11.42 X |
| Revenue | 27.28 B | 9.43 B |
| Gross Profit | 21.62 B | 27.38 B |
| EBITDA | 6.75 B | 3.9 B |
| Net Income | 4.59 B | 570.98 M |
| Cash And Equivalents | 28.36 B | 2.7 B |
| Cash Per Share | 22.39 X | 5.01 X |
| Total Debt | 25.18 B | 5.32 B |
| Debt To Equity | 117.00 % | 48.70 % |
| Current Ratio | 3.76 X | 2.16 X |
| Book Value Per Share | 17.01 X | 1.93 K |
| Cash Flow From Operations | 9.07 B | 971.22 M |
| Earnings Per Share | 9.63 X | 3.12 X |
| Price To Earnings To Growth | 0.71 X | 4.89 X |
| Number Of Employees | 31 | 18.84 K |
| Beta | 0.41 | -0.15 |
| Market Capitalization | 572.2 B | 19.03 B |
| Total Asset | 63.17 B | 29.47 B |
| Z Score | 13.2 | 8.72 |
| Annual Yield | 0.03 % | |
| Net Asset | 63.17 B | |
| Last Dividend Paid | 2.92 |
Gilead Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Gilead . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 273.0 | |||
| Day Typical Price | 273.0 | |||
| Price Action Indicator | (1.44) | |||
| Period Momentum Indicator | (2.87) | |||
| Relative Strength Index | 53.33 |
About Gilead Sciences Buy or Sell Advice
When is the right time to buy or sell Gilead Sciences? Buying financial instruments such as Gilead Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Gilead Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Oil And Gas Thematic Idea Now
Oil And Gas
Companies involved in drilling, production, and distribution of oil and gas pipelines. The Oil And Gas theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Oil And Gas Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Gilead Stock
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:Check out Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.